Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Adam Scott Feldman, M.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring
Diagnostic success and prediction of tumor subtype of renal mass biopsy improves with experience: longitudinal results in a single series cohort of 1233 tumors
Full Time/Year Long, 05/01/14 - 05/01/15

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Salari K, Feldman AS. Re: Salari et al. Active Surveillance of Prostate Cancer is a Viable Option for Men Younger than 60 Years. JUrol. Vol 201, 721-727, April 2019. J Urol. 2019 Jun 04; 101097JU0000000000000363. PMID: 31163004.
    Citations:    
  2. Hanna N, Wszolek MF, Mojtahed A, Nicaise E, Wu B, Gelpi-Hammerschmidt FJ, Salari K, Dahl DM, Blute ML, Harisinghani M, Feldman AS. MULTIPARAMETRIC MRI/ULTRASOUND FUSION BIOPSY IMPROVES BUT DOES NOT REPLACE STANDARD TEMPLATE BIOPSY FOR THE DETECTION OF PROSTATE CANCER. J Urol. 2019 May 30; 101097JU0000000000000359. PMID: 31144593.
    Citations:    
  3. Salari K, Kuppermann D, Preston MA, Dahl DM, Barrisford GW, Efstathiou JA, Blute ML, Vesprini D, Loblaw A, Zietman AL, Klotz L, Feldman AS. Active Surveillance of Prostate Cancer is a Viable Option for Men Younger than 60 Years. J Urol. 2019 04; 201(4):721-727. PMID: 30664083.
    Citations:    Fields:    
  4. Sanchez A, Feldman AS, Hakimi AA. Current Management of Small Renal Masses, Including Patient Selection, Renal Tumor Biopsy, Active Surveillance, and Thermal Ablation. J Clin Oncol. 2018 Oct 29; JCO2018792341. PMID: 30372390.
    Citations:    Fields:    
  5. Royce TJ, Feldman AS, Mossanen M, Yang JC, Shipley WU, Pandharipande PV, Efstathiou JA. Comparative Effectiveness of Bladder-preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer. Clin Genitourin Cancer. 2019 Feb; 17(1):23-31.e3. PMID: 30482661.
    Citations:    Fields:    
  6. Coutifaris C, Kilcoyne A, Feldman AS, Sabatini ME, Oliva E. Case 29-2018: A 31-Year-Old Woman with Infertility. N Engl J Med. 2018 Sep 20; 379(12):1162-1172. PMID: 30231229.
    Citations:    Fields:    Translation:Humans
  7. Cetrulo CL, Li K, Salinas HM, Treiser MD, Schol I, Barrisford GW, McGovern FJ, Feldman AS, Grant MT, Tanrikut C, Lee JH, Ehrlichman RJ, Holzer PW, Choy GM, Liu RW, Ng ZY, Lellouch AG, Kurtz JM, Austen WG, Winograd JM, Bojovic B, Eberlin KR, Rosales IA, Colvin RB, Ko DSC. Penis Transplantation: First US Experience. Ann Surg. 2018 May; 267(5):983-988. PMID: 28509699.
    Citations: 5     Fields:    
  8. Liu Q, Gheorghiu L, Drumm M, Clayman R, Eidelman A, Wszolek MF, Olumi A, Feldman A, Wang M, Marcar L, Citrin DE, Wu CL, Benes CH, Efstathiou JA, Willers H. PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53. Oncogene. 2018 05; 37(21):2793-2805. PMID: 29511347.
    Citations: 1     Fields:    
  9. Tricoli L, Naeem A, Parasido E, Mikhaiel JP, Choudhry MU, Berry DL, Abdelgawad IA, Lee RJ, Feldman AS, Ihemelandu C, Avantaggiati M, Kumar D, Byers S, Gallagher R, Wulfkuhle J, Petricoin E, Rodriguez O, Albanese C. Characterization of the effects of defined, multidimensional culture conditions on conditionally reprogrammed primary human prostate cells. Oncotarget. 2018 Jan 05; 9(2):2193-2207. PMID: 29416764.
    Citations:    Fields:    
  10. Morgan TM, Mehra R, Tiemeny P, Wolf JS, Wu S, Sangale Z, Brawer M, Stone S, Wu CL, Feldman AS. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma. Eur Urol. 2018 05; 73(5):763-769. PMID: 29249291.
    Citations: 1     Fields:    
  11. Sanchez A, Wszolek MF, Niemierko A, Clayman RH, Drumm M, Rodríguez D, Feldman AS, Dahl DM, Heney NM, Shipley WU, Zietman AL, Efstathiou JA. Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder Cancer. J Urol. 2018 02; 199(2):407-415. PMID: 28870862.
    Citations: 1     Fields:    
  12. Rodin D, Drumm M, Clayman R, Buscariollo DL, Galland-Girodet S, Eidelman A, Feldman AS, Dahl DM, McGovern FJ, Olumi AF, Niemierko A, Shipley WU, Zietman AL, Efstathiou JA. Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experience. Clin Genitourin Cancer. 2017 Aug 03. PMID: 28864223.
    Citations: 1     Fields:    
  13. Zhou W, Uppot RN, Feldman AS, Arellano RS. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center. AJR Am J Roentgenol. 2017 Oct; 209(4):733-739. PMID: 28678572.
    Citations: 1     Fields:    Translation:Humans
  14. Dhyani M, Grajo JR, Rodriguez D, Chen Z, Feldman A, Tambouret R, Gervais DA, Arellano RS, Hahn PF, Samir AE. Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms. Abdom Radiol (NY). 2017 06; 42(6):1734-1743. PMID: 28197683.
    Citations: 1     Fields:    Translation:Humans
  15. Feldman AS, Meyer CP, Sanchez A, Krasnova A, Reznor G, Menon M, Kibel AS, Choueiri TK, Lipsitz SR, Sun M, Trinh QD. Morbidity and Mortality of Locally Advanced Prostate Cancer: A Population Based Analysis Comparing Radical Prostatectomy versus External Beam Radiation. J Urol. 2017 11; 198(5):1061-1068. PMID: 28552709.
    Citations: 1     Fields:    
  16. Chen AL, Brown PA, Sweeney BJ, Feldman AS, Arellano RS, Tambouret RH. Smears are important for adequate cytologic diagnosis of kidney lesions. J Am Soc Cytopathol. 2017 Jul - Aug; 6(4):162-169. PMID: 31043269.
    Citations:    
  17. Giacalone NJ, Shipley WU, Clayman RH, Niemierko A, Drumm M, Heney NM, Michaelson MD, Lee RJ, Saylor PJ, Wszolek MF, Feldman AS, Dahl DM, Zietman AL, Efstathiou JA. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience. Eur Urol. 2017 06; 71(6):952-960. PMID: 28081860.
    Citations: 7     Fields:    Translation:Humans
  18. Krasnow RE, Drumm M, Roberts HJ, Niemierko A, Wu CL, Wu S, Zhang J, Heney NM, Wszolek MF, Blute ML, Feldman AS, Lee RJ, Zietman AL, Shipley WU, Efstathiou JA. Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy. Eur Urol. 2017 07; 72(1):54-60. PMID: 28040351.
    Citations: 3     Fields:    Translation:Humans
  19. Buscariollo DL, Drumm M, Niemierko A, Clayman RH, Galland-Girodet S, Rodin D, Feldman AS, M Dahl D, McGovern FJ, F Olumi A, Eidelman A, Shipley WU, Zietman AL, Efstathiou JA. Long-term results of adjuvant versus early salvage postprostatectomy radiation: A large single-institutional experience. Pract Radiat Oncol. 2017 Mar - Apr; 7(2):e125-e133. PMID: 28274403.
    Citations: 3     Fields:    Translation:Humans
  20. Mak KS, Smith AB, Eidelman A, Clayman R, Niemierko A, Cheng JS, Matthews J, Drumm MR, Nielsen ME, Feldman AS, Lee RJ, Zietman AL, Chen RC, Shipley WU, Milowsky MI, Efstathiou JA. Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer. Int J Radiat Oncol Biol Phys. 2016 12 01; 96(5):1028-1036. PMID: 27727064.
    Citations: 6     Fields:    Translation:Humans
  21. Sheth RA, Feldman AS, Paul E, Thiele EA, Walker TG. Sporadic versus Tuberous Sclerosis Complex-Associated Angiomyolipomas: Predictors for Long-Term Outcomes following Transcatheter Embolization. J Vasc Interv Radiol. 2016 Oct; 27(10):1542-9. PMID: 27522275.
    Citations: 1     Fields:    Translation:Humans
  22. Preston MA, Batista JL, Wilson KM, Carlsson SV, Gerke T, Sjoberg DD, Dahl DM, Sesso HD, Feldman AS, Gann PH, Kibel AS, Vickers AJ, Mucci LA. Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer. J Clin Oncol. 2016 08 10; 34(23):2705-11. PMID: 27298404.
    Citations: 11     Fields:    Translation:Humans
  23. Feldman AS. POINT: Is Immediate Radical Cystectomy Justified When Non-Muscle-Invasive Bladder Cancer First Presents as High-Grade T1 Urothelial Carcinoma on Re-Resection? Oncology (Williston Park). 2016 Jun; 30(6):541-2, 545. PMID: 27311841.
    Citations:    Fields:    Translation:Humans
  24. Baumann BC, Bosch WR, Bahl A, Birtle AJ, Breau RH, Challapalli A, Chang AJ, Choudhury A, Daneshmand S, El-Gayed A, Feldman A, Finkelstein SE, Guzzo TJ, Hilman S, Jani A, Malkowicz SB, Mantz CA, Master V, Mitra AV, Murthy V, Porten SP, Richaud PM, Sargos P, Efstathiou JA, Eapen LJ, Christodouleas JP. Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy. Int J Radiat Oncol Biol Phys. 2016 09 01; 96(1):78-86. PMID: 27511849.
    Citations: 5     Fields:    Translation:Humans
  25. Sheth RA, Feldman AS, Paul E, Thiele EA, Walker TG. Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis. World J Radiol. 2016 Mar 28; 8(3):308-15. PMID: 27027863.
    Citations: 5     
  26. Sanchez A, Rodríguez D, Allard CB, Bechis SK, Sullivan RJ, Boeke CE, Kuppermann D, Cheng JS, Barrisford GW, Preston MA, Feldman AS. Primary genitourinary melanoma: Epidemiology and disease-specific survival in a large population-based cohort. Urol Oncol. 2016 Apr; 34(4):166.e7-14. PMID: 26739672.
    Citations: 3     Fields:    Translation:Humans
  27. Huang J, Dahl DM, Dong L, Liu Q, Cornejo K, Wang Q, Wu S, Feldman AS, Huang Y, Xue W, Wu CL. Preoperative Neutrophil-to-Lymphocyte Ratio and Neutrophilia Are Independent Predictors of Recurrence in Patients with Localized Papillary Renal Cell Carcinoma. Biomed Res Int. 2015; 2015:891045. PMID: 26448948.
    Citations: 8     Fields:    Translation:HumansCells
  28. Barrisford GW, Kreydin EI, Preston MA, Rodriguez D, Harisighani MG, Feldman AS. Role of imaging in testicular cancer: current and future practice. Future Oncol. 2015 Sep; 11(18):2575-86. PMID: 26314944.
    Citations: 1     Fields:    Translation:Humans
  29. Hanske J, Sanchez A, Schmid M, Meyer CP, Abdollah F, Feldman AS, Kibel AS, Sammon JD, Menon M, Eswara JR, Noldus J, Trinh QD. A Comparison of 30-Day Perioperative Outcomes in Open Versus Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Carcinoma: Analysis of 896 Patients from the American College of Surgeons-National Surgical Quality Improvement Program Database. J Endourol. 2015 Sep; 29(9):1052-8. PMID: 25891843.
    Citations: 1     Fields:    Translation:Humans
  30. Preston MA, Feldman AS, Coen JJ, McDougal WS, Smith MR, Paly JJ, Carrasquillo R, Wu CL, Dahl DM, Barrisford GW, Blute ML, Zietman AI. Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 years. Urol Oncol. 2015 Sep; 33(9):383.e9-16. PMID: 26059076.
    Citations: 1     Fields:    Translation:Humans
  31. Rodríguez D, Cornejo KM, Sadow PM, Santiago-Lastra Y, Feldman AS. Myopericytoma tumor of the glans penis. Can J Urol. 2015 Jun; 22(3):7830-3. PMID: 26068635.
    Citations: 2     Fields:    Translation:Humans
  32. Hanske J, Sanchez A, Schmid M, Meyer CP, Abdollah F, Roghmann F, Feldman AS, Kibel AS, Sammon JD, Noldus J, Trinh QD, Eswara JR. Comparison of 30-day perioperative outcomes in adults undergoing open versus minimally invasive pyeloplasty for ureteropelvic junction obstruction: analysis of 593 patients in a prospective national database. World J Urol. 2015 Dec; 33(12):2107-13. PMID: 25966662.
    Citations: 2     Fields:    Translation:Humans
  33. Huang J, Feldman AS, Dong L, Cornejo K, Liu Q, Dahl DM, Wu S, Blute ML, Huang Y, Wu CL. Preoperative Anemia as an Independent Prognostic Indicator of Papillary Renal Cell Carcinoma. Clin Genitourin Cancer. 2015 Oct; 13(5):e353-60. PMID: 25998556.
    Citations: 1     Fields:    Translation:Humans
  34. Ringer L, Sirajuddin P, Tricoli L, Waye S, Choudhry MU, Parasido E, Sivakumar A, Heckler M, Naeem A, Abdelgawad I, Liu X, Feldman AS, Lee RJ, Wu CL, Yenugonda V, Kallakury B, Dritschilo A, Lynch J, Schlegel R, Rodriguez O, Pestell RG, Avantaggiati ML, Albanese C. The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells. Oncotarget. 2014 Nov 15; 5(21):10678-91. PMID: 25296977.
    Citations: 17     Fields:    Translation:HumansCells
  35. Rodríguez D, Preston MA, Barrisford GW, Olumi AF, Feldman AS. Clinical features of leiomyosarcoma of the urinary bladder: analysis of 183 cases. Urol Oncol. 2014 Oct; 32(7):958-65. PMID: 25027684.
    Citations: 5     Fields:    Translation:Humans
  36. Yang P, Cornejo KM, Sadow PM, Cheng L, Wang M, Xiao Y, Jiang Z, Oliva E, Jozwiak S, Nussbaum RL, Feldman AS, Paul E, Thiele EA, Yu JJ, Henske EP, Kwiatkowski DJ, Young RH, Wu CL. Renal cell carcinoma in tuberous sclerosis complex. Am J Surg Pathol. 2014 Jul; 38(7):895-909. PMID: 24832166.
    Citations: 25     Fields:    Translation:Humans
  37. Sheth RA, Feldman AS, Walker TG. Renoduodenal fistula after transcatheter embolization of renal angiomyolipoma. Cardiovasc Intervent Radiol. 2015 Feb; 38(1):232-5. PMID: 24722895.
    Citations: 4     Fields:    Translation:Humans
  38. Pollock CB, McDonough S, Wang VS, Lee H, Ringer L, Li X, Prandi C, Lee RJ, Feldman AS, Koltai H, Kapulnik Y, Rodriguez OC, Schlegel R, Albanese C, Yarden RI. Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogrammed primary prostate cancer cells. Oncotarget. 2014 Mar 30; 5(6):1683-98. PMID: 24742967.
    Citations: 15     Fields:    Translation:HumansCells
  39. Hedgire SS, Tabatabaei S, McDermott S, Feldman A, Dahl DM, Harisinghani MG. Diversion ahead: imaging appearance of urinary diversions and reservoirs. Clin Imaging. 2014 Jul-Aug; 38(4):418-427. PMID: 24602415.
    Citations:    Fields:    Translation:Humans
  40. Xu R, Horick N, McGovern FJ, Dahl DM, Feldman AS, Blute ML, Olumi AF, Michaelson MD. Prognostic significance of indeterminate lung nodules in renal cell carcinoma. Urol Oncol. 2014 Apr; 32(3):355-61. PMID: 24397994.
    Citations: 1     Fields:    Translation:Humans
  41. Leung CP, Klausner AP, Habibi JR, King AB, Feldman A. Audience response system: a new learning tool for urologic conferences. Can J Urol. 2013 Dec; 20(6):7042-5. PMID: 24331346.
    Citations: 1     Fields:    Translation:Humans
  42. Kreydin EI, Barrisford GW, Feldman AS, Preston MA. Testicular cancer: what the radiologist needs to know. AJR Am J Roentgenol. 2013 Jun; 200(6):1215-25. PMID: 23701056.
    Citations: 3     Fields:    Translation:Humans
  43. Horick N, McGovern FJ, Dahl DM, Feldman AS, Blute ML, Olumi AF, Michaelson MD. Prognostic significance of indeterminate lung nodules in renal cell carcinoma. J Clin Oncol. 2013 Feb 20; 31(6_suppl):377. PMID: 28136903.
    Citations:    
  44. Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol. 2013 Mar; 63(3):486-92. PMID: 22959191.
    Citations: 49     Fields:    Translation:Humans
  45. Fernandez CA, Millholland JM, Zwarthoff EC, Feldman AS, Karnes RJ, Shuber AP. A noninvasive multi-analyte diagnostic assay: combining protein and DNA markers to stratify bladder cancer patients. Res Rep Urol. 2012; 4:17-26. PMID: 24199176.
    Citations: 4     
  46. Psutka SP, Olumi AF, Feldman AS, Saylor PJ, Kaufman DS, Lee RJ. Pathologic down-staging and complete pathologic response with gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder. J Clin Oncol. 2012 Feb 10; 30(5_suppl):307. PMID: 28143141.
    Citations:    
  47. Psutka SP, McGovern FJ, Mueller P, McDougal WS, Gervais D, Feldman AS. Long-term durable oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. J Clin Oncol. 2012 Feb 10; 30(5_suppl):384. PMID: 28143317.
    Citations:    
  48. Gershman B, Zietman AL, Feldman AS, McDougal WS. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies. Urol Oncol. 2013 Oct; 31(7):1093-7. PMID: 22305626.
    Citations: 9     Fields:    Translation:Humans
  49. Feldman AS, McDougal WS. Long-term outcome of excisional organ sparing surgery for carcinoma of the penis. J Urol. 2011 Oct; 186(4):1303-7. PMID: 21862071.
    Citations: 5     Fields:    Translation:Humans
  50. Psutka SP, Feldman AS, Rodin D, Olumi AF, Wu CL, McDougal WS. Men with organ-confined prostate cancer and positive surgical margins develop biochemical failure at a similar rate to men with extracapsular extension. Urology. 2011 Jul; 78(1):121-5. PMID: 21411125.
    Citations: 5     Fields:    Translation:Humans
  51. Siddiqui MM, Feldman AS. Advances in the evaluation and management of lymph node involvement in urothelial carcinoma of the bladder. Expert Rev Anticancer Ther. 2010 Dec; 10(12):1855-9. PMID: 21110750.
    Citations:    Fields:    Translation:Humans
  52. Coen JJ, Feldman AS, Smith MR, Zietman AL. Watchful waiting for localized prostate cancer in the PSA era: what have been the triggers for intervention? BJU Int. 2011 May; 107(10):1582-6. PMID: 20860650.
    Citations: 6     Fields:    Translation:Humans
  53. Pandharipande PV, Gervais DA, Hartman RI, Harisinghani MG, Feldman AS, Mueller PR, Gazelle GS. Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis. Radiology. 2010 Sep; 256(3):836-46. PMID: 20720070.
    Citations: 14     Fields:    Translation:Humans
  54. Kubota K, Anjum R, Yu Y, Kunz RC, Andersen JN, Kraus M, Keilhack H, Nagashima K, Krauss S, Paweletz C, Hendrickson RC, Feldman AS, Wu CL, Rush J, Villén J, Gygi SP. Sensitive multiplexed analysis of kinase activities and activity-based kinase identification. Nat Biotechnol. 2009 Oct; 27(10):933-40. PMID: 19801977.
    Citations: 33     Fields:    Translation:HumansCells
  55. Tanrikut C, Feldman AS, Altemus M, Paduch DA, Schlegel PN. Adverse effect of paroxetine on sperm. Fertil Steril. 2010 Aug; 94(3):1021-6. PMID: 19515367.
    Citations: 30     Fields:    Translation:HumansCells
  56. Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet. 2009 Jul 18; 374(9685):239-49. PMID: 19520422.
    Citations: 279     Fields:    Translation:Humans
  57. Feldman AS, Banyard J, Wu CL, McDougal WS, Zetter BR. Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression. Clin Cancer Res. 2009 Feb 01; 15(3):1024-31. PMID: 19188175.
    Citations: 17     Fields:    Translation:Humans
  58. Eisner BH, Feldman AS. Nanoparticle imaging for genitourinary cancers. Cancer Biomark. 2009; 5(2):75-9. PMID: 19414924.
    Citations: 3     Fields:    Translation:Humans
  59. Feldman AS and McDougal WS. Inguinal Node Dissection for Penile Carcinoma. AUA Update. 2008.
  60. Feldman AS, McDougal WS, Harisinghani MG. The potential of nanoparticle-enhanced imaging. The Journal of Urologic Oncology, Seminar Section. 2008; 26(1):65-73.
  61. Feldman AS, McDougal WS, Harisinghani MG. The potential of nanoparticle-enhanced imaging. Urol Oncol. 2008 Jan-Feb; 26(1):65-73. PMID: 18190834.
    Citations: 5     Fields:    Translation:Humans
  62. Kaufman DS, Shipley WU, Feldman AS. Review on Bladder Cancer. The Lancet. 2007; Submitted.
  63. Feldman AS, Banyard J, Wu CL, McDougal WS, Zetter BR. . Proteomic discovery and analysis of Cystatin B, a novel biomarker in transitional cell carcinoma. Presented at the American Urological Association and ASCO GU Cancer Symposium. 2007.
  64. Banyard J, Bao L, Hofer MD, Zurakowski D, Spivey KA, Feldman AS, Hutchinson LM, Kuefer R, Rubin MA, Zetter BR. Collagen XXIII expression is associated with prostate cancer recurrence and distant metastases. Clin Cancer Res. 2007 May 01; 13(9):2634-42. PMID: 17473194.
    Citations: 12     Fields:    Translation:HumansCells
  65. Eisner BH, Feldman AS, Chapin BF, Dretler SP. "Blind coning"--using the Stone Cone for removal of intramural ureteral calculi. Urology. 2007 Apr; 69(4):773-5. PMID: 17445670.
    Citations:    Fields:    Translation:Humans
  66. Feldman AS and Dahl DM. , 2006. June, 2-6, 2006. Laparoscopic Radical Prostatectomy. US Oncological Disease 2006. 2006; 56-58.
  67. Feldman AS, Gervais D, Cutie CJ, Mueller PR, McDougal WS. . A comparison of nephron sparing techniques: percutaneous radiofrequency ablation (RFA) vs. open and laparoscopic partial nephrectomy. Presented at the Society of Urologic Oncology, 2005 and American Urological Association. 2006.
  68. Feldman AS, Bauer SB. Diagnosis and management of dysfunctional voiding. Curr Opin Pediatr. 2006 Apr; 18(2):139-47. PMID: 16601493.
    Citations: 15     Fields:    Translation:Humans
  69. Zetter BR, Feldman AS, McDougal WS. Methods for diagnosis and prognosis of epithelial cancers. 2006.
  70. Feldman AS, Hutchinson LM, McDougal WS, Zetter BR. . Biomarker profiling and novel approach to biomarker normalization for prostate cancer diagnosis using post-DRE voided urine specimens. Presented at the Multidisciplinary Prostate Cancer Symposium. 2005.
  71. Feldman AS, Hutchinson LM, McDougal WS, Zetter BR. Proteomic analysis of post-DRE voided urine specimens for prostate cancer biomarker discovery. Presented at the Multidisciplinary Prostate Cancer Symposium. 2005.
  72. Feldman AS, Hutchinson LM, McDougal WS, Zetter BR. . Proteomic analysis of voided urine, bladder cancer tissue and cell lines for biomarker discovery in transitional cell carcinoma. Presented at the Scientific Advisory Committee Meeting, Massachusetts General Hospital. 2005.
  73. Feldman AS, Gargollo PC, Grocela JA. Genitourinary Trauma. In: Sheridan RL, Ed. The Trauma Handbook of the Massachusetts General Hospital. 2004; 584-508.
  74. Feldman A, Kirley S, McDougal WS, Zukerberg LR, Wu CL. . The expression of cables, a cell cycle regulatory gene is progressively lost in human prostate cancer as Gleason score increases. Presented at American Urological Association. 2004.
  75. Feldman A, Tang Z, Kirley S, McDougal WS, Zukerberg LR, Wu CL. . Expression of cables, a cell cycle regulatory gene is lost in invasive transitional cell carcinoma of the bladder. Presented at American Urological Association. 2003.
  76. Feldman A, Kirley S, McDougal WS, Zukerberg LR, Wu CL. . Expression of cables, a cell cycle regulatory gene is lost in human prostate cancer and suppresses prostate cancer cell growth. Presented at American Urological Association. 2003.
  77. Feldman A, Kirley S, McDougal WS, Zukerberg LR, Wu CL. The role of cables, a putative tumor suppressor gene in urothelial carcinoma. Presented at American Urological Association, New England Section, 2002. The role of cables, a putative tumor suppressor gene in urothelial carcinoma. Presented at American Urological Association, New England Section. 2002.
  78. Soker S, Machado MG, Lu X, Feldman A, Atala A. . Localization of VEGF and its receptors in corpus cavernosa. Presented at American Urological Association. 2000.
  79. Feldman A, Soker S, Lu X, Atala A. . Characterization of the normal expression of angiogenic markers in the rat genitourinary system. Presented at Senior Scholars Presentation Day, University of Massachusetts Medical School. 2000.
  80. Feldman AS. Developmental Lead Exposure and Cognition. 1996.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Feldman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (256)
Explore
_
Co-Authors (78)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.